Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Asia Reg Roundup: Adverse-Event Reporting, Medtech Fees, And More

Executive Summary

Thailand is on the cusp of integrating new medtech adverse-event reporting guidelines, Malaysia is making good headway with its new regulatory system, and the Philippines is moving ahead with plans for a medical device fees schedule. Myanmar and Brunei are among other ASEAN member states included in this latest Asian regulatory update from Medtech Insight.

You may also be interested in...

Asia Reg Roundup: Malaysia, Vietnam & India Speed Ahead In 2017

Progress on ratifying the ASEAN Medical Device Directive (AMDD) continues apace, with some of the Association of Southeast Asian Nations members surging ahead. Malaysia and Vietnam, in particular, are making big efforts to build or strengthen their national regulatory systems foe devices. Also, non-ASEAN state India is taking real steps in a similar direction, say Asia Regulatory Professional Association (ARPA) secretary Jack Wong and ARQon consultant May Ng in this latest Asian regulatory update.

Asia Reg Roundup: Vietnam Decree, Malaysia Labels And More

Medtech companies selling into the Vietnam market need to start preparing for major regulatory changes that will be introduced in 2017 via a new decree. That is the advice of Asia Regulatory Professional Association (ARPA) secretary Jack Wong and ARQon consultant May Ng, who spoke to Medtech Insight on a range of regional Asian regulatory issues for this September update.

Medtech Gets Two Years To Meet Labeling Rules In Malaysia

Malaysia's Medical Device Authority says the newly introduced two-year transition period for companies to comply with labeling rules should help industry keep costs down.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts